Malignant Cervical Neoplasm — Trials

Malignant Cervical Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 506
Recruiting: 280
Ph III recruiting: 34
Growth YoY: −11.9%
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 22.7%
Trials / 1,000 deaths: 121.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 101–108 of 108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06505551	Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma	not yet recruiting	Phase 1 / Phase 2	66	SCG Cell Therapy Pte. Ltd.INDUSTRY	0	Jul 17, 2024	clinicaltrials
NCT05187338	Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors	recruiting	Phase 1 / Phase 2	100	Second Affiliated Hospital of Guangzhou Medical UniversityOTHER	1	Jun 25, 2024	clinicaltrials